Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; ARID; Age Related Immune Differences; CD40L; CD40 ligand; CTLA-4; cytotoxic T lymphocyte antigen-4; IL; interleukin; Lag3; lymphocyte activation gene 3; MDSC; myeloid derived suppressor cell; MHC; major histocompatibility complex; mTOR; mammalian target o
مقالات ISI آنتی ژن لنفوسیت T-4 سیتوتوکسیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; ARID; Age Related Immune Dysfunction; BCG; Bacille Calmette-Guérin; CAR; chimeric antigen receptor; CDMRP; Congressionally Directed Medical Research Program; CD40L; CD40 ligand; CpG; poly-(cysteine 5â² to guanine); CRISPR; clustered regularly interspace
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; Cytotoxic T lymphocyte antigen-4; Programmed cell death-1; Cancer immunotherapy; Tumor immunology; Lymph node; Drug delivery systems; Controlled release; Therapeutic antibody; Immune-related associated toxicity;
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; Gy; gray; Ab; antibody; TGF-β; transforming growth factor-β; TNF; tumor necrosis factor; SASP; senescence-associated secretory phenotype; MCP-1; monocyte chemoattractant protein-1; MHC; major histocompatibility complex; DAMP; damage-associated molecular
The expression of mCTLA-4 in skin lesion inversely correlates with the severity of psoriasis
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; CTLA4; Cytotoxic T lymphocyte antigen-4; sCTLA-4; soluble Cytotoxic T lymphocyte antigen-4; mCTLA-4; membrane Cytotoxic T lymphocyte antigen-4; IOD; Integrated option density; IMQ; Imiquimod; PASI; psoriasis area and severity index; Treg; regulatory T; CT
Fine tuning subsets of CD4+ T cells by low-dosage of IL-2 and a new therapeutic strategy for autoimmune diseases
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; aa; Amino acids; A region; Acidic region of IL-2Rβ; AKT; Protein kinase B; AA; Alopecia Areata; CTLA-4; Cytotoxic T lymphocyte antigen-4; cDNA; Complementary DNA; Foxp3; Forkhead box P3; GVHD; Chronic graft-versus-host disease; HCV; Hepatitis C virus; hd
Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; Autoimmune cytopenias; Immune checkpoint deficiencies; Extensive genetic screening; LRBA and CTLA-4 deficiencies; ES; Evans syndrome; AIHA; Autoimmune hemolytic anemia; ITP; Immune thrombocytopenia; ALPS; Autoimmune lymphoproliferative syndrome; CTLA-4; C
DNA mismatch repair in cancer
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; 5-FU; 5-fluorouracil; bMMRD; Biallelic mismatch repair deficiency; CD28; cluster of differentiation 28; CIN; Chromosomal instable; CR; complete response; CRC; colorectal cancer; CTL; cytotoxic T-lymphocytes; CTLA-4; cytotoxic T lymphocyte antigen-4; DFS;
Combined blockade of Tim-3 and MEK inhibitor enhances the efficacy against melanoma
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; Trametinib; Tim-3; MAPK pathway; Targeted therapy; Cancer immunotherapy; MAPK; mitogen-activated protein kinase; MEK; mitogen-activated extracellular signal-regulated kinase; OS; overall survival; CTLA-4; cytotoxic T lymphocyte antigen-4; PD-1; programmed
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; APC; antigen-presenting cell; cDC; conventional dendritic cell; CTLA-4; cytotoxic T lymphocyte antigen-4; DC; dendritic cell; DUSP; dual-specific phosphatase; GAL-9; galectin-9; ICOS; inducible T cell co-stimulator; ICOSL; inducible T cell co-stimulator l
ReviewCould B7-H4 serve as a target to activate anti-cancer immunity?
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; TCR; T-cell receptor; MHC; major histocompatibility complex; APCs; antigen presenting cells; CTLA-4; cytotoxic T lymphocyte antigen-4; SNP; single nucleotide polymorphism; Tregs; regulatory T-cells; TILs; tumor infiltrating T cells; CAM; cancer-associated
Associate editor: B. TeicherCD70: An emerging target in cancer immunotherapy
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; CD70; CD27; Cancer immunotherapy; Combination therapy; ADCC; Antibody-dependent cellular cytotoxicity; ADCP; Antibody-dependent cellular phagocytosis; CDC; Complement-dependent cellular cytotoxicity; CTLA-4; Cytotoxic T lymphocyte antigen-4; FOXP3; Forkhe
Clinical Application of Basic ScienceIgG4 cholangiopathy - Current concept, diagnosis, and pathogenesis
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; AIP; autoimmune pancreatitis; ANA; anti-nuclear antibody; CA-II; carbonic anhydrase-II; CBD; common bile duct; CTLA-4; cytotoxic T lymphocyte antigen-4; ERCP; endoscopic retrograde cholangio-pancreatography; FCRL; Fc-receptor-like; IFN-γ; interferon-γ;
Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; HCV; hepatitis C virus; GBV-B; GB virus B; PD-1; programmed death receptor-1; PD1-L1; programmed death receptor-1 ligand; CTLA4; cytotoxic T lymphocyte antigen-4; NS; non-structural; vRNA; viral ribonucleic acid; qRT-PCR; quantitative reverse transcriptas
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; BCG; Bacillus Calmette-Guérin; BMDC; bone marrow-derived dendritic cell; CTA; cancer/testis antigen; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T lymphocyte antigen-4; DC; dendritic cell; DNA; deoxyribonucleic acid; DTH; delayed-type hypersensitivity
What are regulatory T cells (Treg) regulating in cancer and why?
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; TGF-β; transforming growth factor beta; nTreg; natural regulatory T cells; iTreg; inducible regulatory T cells; PGE2; prostaglandin E2; COX2; cyclooxygenase 2; TIL; tumor infiltrating lymphocytes; CTL; cytotoxic T lymphocytes; NK cells; natural killer ce
CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; CFSE; 5,6-carboxyfluorescein diacetate succinimidyl ester; CTLA-4; cytotoxic T lymphocyte antigen-4; PKC-Î; protein kinase C Î; PLC-γ1; phospholipase C-γ1; SHP-2; SH2-domain containing protein tyrosine phosphatase 2; Costimulation; Signal transduction
CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; Autoimmunity; Cytotoxic T lymphocyte antigen-4; Genetics; Schizophrenia; Single-nucleotide polymorphism; T cell
Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study
Keywords: آنتی ژن لنفوسیت T-4 سیتوتوکسیک; TILs; Cancer; Cytokines; Fas; Adhesion molecules; APC; antigen presenting cell; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T lymphocyte antigen-4; FasL; Fas ligand; ICAM; intercellular adhesion molecule; IEL; intraepithelial lymphocyte; IFN; interfero